Gilead Sciences, Inc. (GIS.DE)
EUR 91.22
(-1.26%)
EUR 91.22
(-1.26%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 13.49 Billion USD | 10.87% |
| 2022 | 10.65 Billion USD | 0.39% |
| 2021 | 10.6 Billion USD | 4.11% |
| 2020 | 10.19 Billion USD | -24.45% |
| 2019 | 13.48 Billion USD | 48.63% |
| 2018 | 9.07 Billion USD | 19.21% |
| 2017 | 7.61 Billion USD | -10.4% |
| 2016 | 8.49 Billion USD | 31.93% |
| 2015 | 6.44 Billion USD | 10.33% |
| 2014 | 5.83 Billion USD | 52.83% |
| 2013 | 3.81 Billion USD | 18.57% |
| 2012 | 3.22 Billion USD | 30.34% |
| 2011 | 2.47 Billion USD | 16.71% |
| 2010 | 2.11 Billion USD | 12.23% |
| 2009 | 1.88 Billion USD | 23.31% |
| 2008 | 1.52 Billion USD | 17.98% |
| 2007 | 1.29 Billion USD | 35.43% |
| 2006 | 957.52 Million USD | 45.75% |
| 2005 | 656.97 Million USD | 24.82% |
| 2004 | 526.34 Million USD | 23.77% |
| 2003 | 425.24 Million USD | 34.55% |
| 2002 | 316.05 Million USD | 1.73% |
| 2001 | 310.69 Million USD | 37.25% |
| 2000 | 226.36 Million USD | 11.07% |
| 1999 | 203.8 Million USD | 86.8% |
| 1998 | 109.1 Million USD | 24.4% |
| 1997 | 87.7 Million USD | 19.97% |
| 1996 | 73.1 Million USD | 92.88% |
| 1995 | 37.9 Million USD | -13.86% |
| 1994 | 44 Million USD | 20.88% |
| 1993 | 36.4 Million USD | 51.04% |
| 1992 | 24.1 Million USD | 138.61% |
| 1991 | 10.1 Million USD | 46.38% |
| 1990 | 6.9 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 5.32 Billion USD | 76.56% |
| 2024 Q2 | 2.72 Billion USD | -48.08% |
| 2023 Q3 | 2.77 Billion USD | -14.86% |
| 2023 Q1 | 2.76 Billion USD | -22.48% |
| 2023 Q4 | 3.01 Billion USD | 8.8% |
| 2023 FY | 11.8 Billion USD | 10.87% |
| 2023 Q2 | 3.25 Billion USD | 17.72% |
| 2022 Q2 | 2.45 Billion USD | -50.51% |
| 2022 FY | 10.65 Billion USD | 0.39% |
| 2022 Q4 | 3.56 Billion USD | 51.06% |
| 2022 Q3 | 2.36 Billion USD | -3.94% |
| 2022 Q1 | 4.96 Billion USD | 35.14% |
| 2021 Q1 | 2.11 Billion USD | -36.22% |
| 2021 Q2 | 2.48 Billion USD | 17.77% |
| 2021 Q3 | 2.33 Billion USD | -5.96% |
| 2021 Q4 | 3.67 Billion USD | 57.34% |
| 2021 FY | 10.6 Billion USD | 4.11% |
| 2020 Q1 | 2.17 Billion USD | -29.84% |
| 2020 FY | 10.19 Billion USD | -24.45% |
| 2020 Q4 | 3.3 Billion USD | 46.11% |
| 2020 Q3 | 2.26 Billion USD | -10.8% |
| 2020 Q2 | 2.53 Billion USD | 16.58% |
| 2019 Q4 | 3.1 Billion USD | -48.64% |
| 2019 FY | 13.48 Billion USD | 48.63% |
| 2019 Q1 | 2.08 Billion USD | -32.26% |
| 2019 Q2 | 2.25 Billion USD | 8.05% |
| 2019 Q3 | 6.04 Billion USD | 167.94% |
| 2018 FY | 9.07 Billion USD | 19.21% |
| 2018 Q1 | 1.93 Billion USD | -19.48% |
| 2018 Q4 | 3.08 Billion USD | 63.28% |
| 2018 Q3 | 1.88 Billion USD | -13.12% |
| 2018 Q2 | 2.17 Billion USD | 12.31% |
| 2017 FY | 7.61 Billion USD | -10.4% |
| 2017 Q1 | 1.78 Billion USD | -19.05% |
| 2017 Q2 | 1.76 Billion USD | -1.12% |
| 2017 Q3 | 1.66 Billion USD | -5.28% |
| 2017 Q4 | 2.4 Billion USD | 44.0% |
| 2016 Q4 | 2.2 Billion USD | 11.56% |
| 2016 Q3 | 1.97 Billion USD | -16.93% |
| 2016 FY | 8.49 Billion USD | 31.93% |
| 2016 Q2 | 2.37 Billion USD | 21.74% |
| 2016 Q1 | 1.95 Billion USD | 6.97% |
| 2015 Q3 | 1.64 Billion USD | 0.98% |
| 2015 FY | 6.44 Billion USD | 10.33% |
| 2015 Q1 | 1.34 Billion USD | -30.19% |
| 2015 Q2 | 1.63 Billion USD | 21.55% |
| 2015 Q4 | 1.82 Billion USD | 10.75% |
| 2014 FY | 5.83 Billion USD | 52.83% |
| 2014 Q4 | 1.92 Billion USD | 21.94% |
| 2014 Q2 | 1.19 Billion USD | 4.76% |
| 2014 Q3 | 1.57 Billion USD | 31.55% |
| 2014 Q1 | 1.14 Billion USD | 7.31% |
| 2013 FY | 3.81 Billion USD | 18.57% |
| 2013 Q3 | 953.1 Million USD | 2.61% |
| 2013 Q2 | 928.89 Million USD | 6.53% |
| 2013 Q1 | 871.92 Million USD | 8.25% |
| 2013 Q4 | 1.06 Billion USD | 11.77% |
| 2012 Q2 | 728.74 Million USD | -19.15% |
| 2012 Q1 | 901.33 Million USD | 20.43% |
| 2012 FY | 3.22 Billion USD | 30.34% |
| 2012 Q4 | 805.48 Million USD | 2.56% |
| 2012 Q3 | 785.41 Million USD | 7.78% |
| 2011 Q1 | 550.01 Million USD | -18.27% |
| 2011 Q2 | 586.67 Million USD | 6.66% |
| 2011 Q4 | 748.45 Million USD | 27.72% |
| 2011 FY | 2.47 Billion USD | 16.71% |
| 2011 Q3 | 585.99 Million USD | -0.12% |
| 2010 FY | 2.11 Billion USD | 12.23% |
| 2010 Q4 | 672.96 Million USD | 39.91% |
| 2010 Q3 | 480.99 Million USD | 0.4% |
| 2010 Q2 | 479.07 Million USD | -1.08% |
| 2010 Q1 | 484.28 Million USD | -1.88% |
| 2009 Q3 | 497.28 Million USD | -1.15% |
| 2009 Q2 | 503.04 Million USD | 28.09% |
| 2009 Q1 | 392.73 Million USD | -0.71% |
| 2009 Q4 | 493.54 Million USD | -0.75% |
| 2009 FY | 1.88 Billion USD | 23.31% |
| 2008 FY | 1.52 Billion USD | 17.98% |
| 2008 Q4 | 395.52 Million USD | 4.84% |
| 2008 Q3 | 377.25 Million USD | -4.75% |
| 2008 Q2 | 396.07 Million USD | 13.08% |
| 2008 Q1 | 350.25 Million USD | -3.96% |
| 2007 Q2 | 322.11 Million USD | 8.58% |
| 2007 Q4 | 364.69 Million USD | 16.4% |
| 2007 FY | 1.29 Billion USD | 35.43% |
| 2007 Q3 | 313.31 Million USD | -2.73% |
| 2007 Q1 | 296.64 Million USD | 14.66% |
| 2006 FY | 957.52 Million USD | 45.75% |
| 2006 Q4 | 258.71 Million USD | 14.56% |
| 2006 Q3 | 225.83 Million USD | -6.72% |
| 2006 Q2 | 242.1 Million USD | 4.87% |
| 2006 Q1 | 230.86 Million USD | 33.38% |
| 2005 Q2 | 155.24 Million USD | 3.1% |
| 2005 FY | 656.97 Million USD | 24.82% |
| 2005 Q1 | 150.56 Million USD | -3.22% |
| 2005 Q3 | 178.06 Million USD | 14.7% |
| 2005 Q4 | 173.09 Million USD | -2.79% |
| 2004 Q4 | 155.58 Million USD | 27.97% |
| 2004 Q3 | 121.57 Million USD | 1.79% |
| 2004 FY | 526.34 Million USD | 23.77% |
| 2004 Q1 | 129.75 Million USD | -8.79% |
| 2004 Q2 | 119.43 Million USD | -7.96% |
| 2003 Q1 | 88.73 Million USD | -4.22% |
| 2003 Q2 | 98.99 Million USD | 11.56% |
| 2003 Q3 | 95.26 Million USD | -3.77% |
| 2003 Q4 | 142.26 Million USD | 49.34% |
| 2003 FY | 425.24 Million USD | 34.55% |
| 2002 Q2 | 72.45 Million USD | -1.18% |
| 2002 Q4 | 92.63 Million USD | 19.29% |
| 2002 FY | 316.05 Million USD | 1.73% |
| 2002 Q1 | 73.31 Million USD | -14.82% |
| 2002 Q3 | 77.65 Million USD | 7.18% |
| 2001 Q3 | 402.57 Million USD | 445.61% |
| 2001 FY | 310.69 Million USD | 37.25% |
| 2001 Q1 | 73.05 Million USD | 4.76% |
| 2001 Q2 | 73.78 Million USD | 1.0% |
| 2001 Q4 | 86.07 Million USD | -78.62% |
| 2000 FY | 226.36 Million USD | 11.07% |
| 2000 Q4 | 69.73 Million USD | 17.49% |
| 2000 Q3 | 59.35 Million USD | 18.33% |
| 2000 Q2 | 50.16 Million USD | 6.48% |
| 2000 Q1 | 47.1 Million USD | -12.6% |
| 1999 Q1 | 25 Million USD | -16.39% |
| 1999 Q2 | 27 Million USD | 8.0% |
| 1999 Q3 | 55.1 Million USD | 104.07% |
| 1999 Q4 | 53.9 Million USD | -2.18% |
| 1999 FY | 203.8 Million USD | 86.8% |
| 1998 Q1 | 26.3 Million USD | -5.4% |
| 1998 FY | 109.1 Million USD | 24.4% |
| 1998 Q4 | 29.9 Million USD | 18.18% |
| 1998 Q2 | 27.4 Million USD | 4.18% |
| 1998 Q3 | 25.3 Million USD | -7.66% |
| 1997 Q4 | 27.8 Million USD | 34.95% |
| 1997 Q2 | 21.5 Million USD | 21.47% |
| 1997 Q1 | 17.7 Million USD | -4.32% |
| 1997 FY | 87.7 Million USD | 19.97% |
| 1997 Q3 | 20.6 Million USD | -4.19% |
| 1996 FY | 73.1 Million USD | 92.88% |
| 1996 Q4 | 18.5 Million USD | -5.61% |
| 1996 Q3 | 19.6 Million USD | -1.01% |
| 1996 Q2 | 19.8 Million USD | 30.26% |
| 1996 Q1 | 15.2 Million USD | 0.0% |
| 1995 Q2 | 11 Million USD | -8.33% |
| 1995 Q3 | 12.1 Million USD | 10.0% |
| 1995 FY | 37.9 Million USD | -13.86% |
| 1995 Q1 | 12 Million USD | -9.77% |
| 1994 Q3 | 3.3 Million USD | -67.33% |
| 1994 Q4 | 13.3 Million USD | 303.03% |
| 1994 FY | 44 Million USD | 20.88% |
| 1994 Q1 | 11 Million USD | 14.58% |
| 1994 Q2 | 10.1 Million USD | -8.18% |
| 1993 Q4 | 9.6 Million USD | 14.29% |
| 1993 Q1 | 8.3 Million USD | 27.69% |
| 1993 FY | 36.4 Million USD | 51.04% |
| 1993 Q2 | 7.3 Million USD | -12.05% |
| 1993 Q3 | 8.4 Million USD | 15.07% |
| 1992 Q4 | 6.5 Million USD | 27.45% |
| 1992 Q3 | 5.1 Million USD | 18.6% |
| 1992 Q1 | -9.1 Million USD | 0.0% |
| 1992 FY | 24.1 Million USD | 138.61% |
| 1992 Q2 | 4.3 Million USD | 147.25% |
| 1991 Q1 | -6.1 Million USD | 0.0% |
| 1991 Q4 | - USD | 0.0% |
| 1991 FY | 10.1 Million USD | 46.38% |
| 1991 Q2 | - USD | 100.0% |
| 1991 Q3 | - USD | 0.0% |
| 1990 Q2 | - USD | 0.0% |
| 1990 FY | 6.9 Million USD | 0.0% |
| 1990 Q3 | - USD | 0.0% |
| 1990 Q4 | - USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Bayer Aktiengesellschaft | 27.88 Billion EUR | 51.621% |
| Sanofi | 23.94 Billion EUR | 43.647% |